Chapter 1 Notes: The Immune System

Historical Orientation

• Immunology: the study of the immune system, a system of cells, tissues, and soluble products that recognizes, attacks, and destroys entities that threaten health.

• Immunity derives from immunitas (Latin): “to be exempt from.” Origin of the term from observed resistance after first exposure.

• Edward Jenner (1796) solidified immunology as a science through smallpox vaccination concept using cowpox; dairymaids and cattle workers showed resistance to smallpox.

• Jenner exposed an 8-year-old to cowpox, then to smallpox; the child did not develop smallpox. This demonstrated immune protection via vaccination.

• Jenner’s vaccination led to global adoption; the 1967 WHO campaign aimed to eradicate smallpox, achieved in 1980.

• Pasteur extended Jenner’s technique to animals and coined the term vaccination (from Latin vaccinus, derived from cows).

• The broader science of immunology emerged from Pasteur’s work; immunology is the study of the cells, tissues, genes, and proteins underlying immunity.

• Nobel Prize laureates and landmark discoveries are highlighted in Appendices A and B of the chapter.

• Francis Bacon quote: “Books must follow sciences, and not sciences books.”

The Nature of the Immune Response

• The immune system maintains homeostasis: balance among organs and systems; responds to trauma, pathogens, and deregulated cells (e.g., cancer).

• Immune responses aim to identify and clear damaged/dying cells and counteract infectious agents (bacteria, viruses, parasites, fungi).

• Pathogens are ubiquitous; despite eradication successes (e.g., smallpox), infectious diseases remain major global killers.

• The body is constantly surrounded by microbes; most are harmless or beneficial, but some are pathogenic.

• Infection: attachment and entry of a pathogen into the host; replication within or outside host cells.

• Extracellular pathogens replicate in interstitial fluid before possibly disseminating via blood.

• Intracellular pathogens enter host cells and use host machinery to reproduce; they may spread systemically via blood.

• Illness/disease results if infection overwhelms host defenses or disrupts cellular functions.

• The immune response aims to eliminate infection and prevent damage to neighboring cells; immune surveillance is ongoing.

• Immune responses can cause collateral tissue damage (immunopathology), usually temporary in healthy individuals.

Types of Immune Responses: Innate and Adaptive

• Vertebrates exhibit a continuum of immune responses, with increasing precision of weaponry as needed.

• Innate immunity is involved at all levels and is the first line of defense; adaptive immunity is mounted when innate mechanisms signal a serious infection.

• The goal of both arms is to clear unwanted entities and restore homeostasis efficiently.

Interplay between the Innate and Adaptive Responses

• Innate and adaptive responses are not strictly separate; they operate in a continuum and reinforce each other.

• Innate responses provide the initial, broad defense and can trigger adaptive responses when necessary.

• Adaptive responses provide targeted, specific defense and can enhance innate immunity via cytokines and cell–cell interactions.

Clinical Immunology

• A healthy immune system protects against infections and cancer; localized inflammation is a normal byproduct.

• Immunization (vaccination) can boost robustness of the immune system.

• Immunodeficiencies can be either congenital (primary) or acquired (secondary), increasing susceptibility to infections and cancer.

• Immunopathology: when immune responses cause disease such as transplant rejection, autoimmunity, hypersensitivity, or chronic inflammation.

• The chapter outlines how immune dysregulation can contribute to disease; future chapters cover detailed mechanisms and clinical implications.

General Features of Innate Immunity

• Innate immunity is the body’s immediate, non-specific defense; it relies on pre-existing barriers and rapid responses.

• i) Barrier Defense: non-inducible physical, chemical, and molecular barriers (e.g., intact skin; low stomach pH; hydrolytic enzymes in secretions).

• ii) Complement Activation: inducible enzyme system that enhances innate and adaptive defenses after barrier breach (inactive in circulation until activated).

• iii) Pattern Recognition: recognition of PAMPs (pathogen-associated molecular patterns) and DAMPs (damage-associated molecular patterns) by pattern recognition molecules (PRMs).

• PRMs include PRRs (pattern recognition receptors) on innate leukocytes, soluble PRMs, and PRMs in endosomes.

• Upon PRR engagement, innate leukocytes activates effector mechanisms: inflammation, phagocytosis, and/or target cell lysis.

• iv) Inflammation: cytokine-mediated recruitment of innate and possibly adaptive leukocytes to injury or infection; localized redness and swelling are signs; resolution should occur, but chronic inflammation is immunopathic.

• v) Phagocytosis: neutrophils, macrophages, and dendritic cells (DCs) engulf pathogens and debris; DCs also present antigens to adaptive cells.

• vi) Target Cell Lysis: innate effectors (neutrophils, macrophages, NK cells) lyse cancer or infected cells identified by DAMPs/PAMPs.

General Features of Adaptive Immunity

• Adaptive immunity involves lymphocytes: B cells and T cells (Th, Tc).

• Key features include specificity, division of labor, memory, diversity, and tolerance.

• i) Specificity: antigen receptors on B cells (BCRs) and T cells (TCRs) are highly specific; activation triggers proliferation and effector differentiation.

• BCRs bind intact antigens; B cells proliferate into plasma cells producing antibodies (humoral immunity).

• TCRs recognize peptide–MHC complexes and require antigen presentation by APCs; effector T cells (Tc and Th) have distinct roles.

• ii) Division of Labor: B cells (antibody-mediated humoral response) vs Tc cells (cell-mediated cytotoxic response) vs Th cells (helper functions and cytokine support).

• B cells respond to extracellular pathogens; Tc and Th cells mediate intracellular and coordinated responses.

• iii) Immunological Memory: adaptive immunity creates memory cells after primary exposure, enabling faster, stronger responses upon re-exposure (secondary response).

• Primary response involves clonal selection and expansion to generate effector and memory cells; secondary response is accelerated and robust due to memory cells.

• NOTE: Immunological memory is the basis of vaccination.

• iv) Diversity: adaptive repertoire is nearly limitless due to somatic recombination and gene rearrangements in BCR and TCR genes, generating vast antigen receptor diversity.

• The BCR and TCR genes are assembled from multiple gene segments via somatic recombination, creating diverse receptor sequences; B cells also undergo somatic hypermutation for further diversification.

• v) Tolerance: mechanisms prevent auto-reactivity; central tolerance eliminates self-reactive clones during development; peripheral tolerance silences autoreactive clones that escape central tolerance.

Antigen Recognition and Receptors

• Antigens: structures that trigger adaptive responses; initially named for antibody generation, now broader as structures targeted by humoral or cell-mediated responses.

• B cells recognize intact antigens via the BCR; activated B cells proliferate into plasma cells that secrete antibodies (humoral response).

• Antibodies: soluble, secreted forms of BCRs; circulate and bind to antigens to promote clearance; not able to penetrate cell membranes to reach intracellular pathogens.

• T cells recognize peptide–MHC (pMHC) complexes displayed by APCs; two major pathways:

  • Tc cells recognize peptide–MHC class I complexes, leading to cytotoxic activity and lysis of infected cells (CTLs).

  • Th cells recognize peptide–MHC class II complexes on professional APCs and secrete cytokines to activate B cells and Tc cells; Th also stimulates innate leukocytes.

• Antigen presentation by DCs: extracellular antigens can be captured by phagocytosis; intracellular antigens by infection or phagocytosis of debris; peptides are bound to MHC molecules and displayed on DC surface.

• MHC: major histocompatibility complex; genes located on chromosome 6; MHC class I molecules present to Tc cells; MHC class II molecules present to Th cells; detailed in Chapter 6.

• Cytokines from Th cells support activation of B and Tc cells and reinforce innate immunity.

Clonal Selection and Immunological Memory

• Immunological memory arises via clonal selection: antigen-specific lymphocytes proliferate and differentiate into effector and memory cells.

• Primary immune response: initial clonal activation and generation of effector cells to eliminate pathogen; memory cells persist for long-term protection.

• Secondary immune response: memory cells respond rapidly and robustly upon re-exposure, producing stronger and faster protection.

• Memory generation is the basis for vaccination; memory B and T cells persist in tissues in a resting state until reactivated.

• Figures referenced (e.g., Fig. 1-6) illustrate clonal selection and memory/effector differentiation.

Diversity of the Antigen Receptor Repertoire

• Adaptive receptor diversity is vastly greater than innate recognition and can recognize synthetic antigens as well.

• Diversity arises from genetic mechanisms before and after antigen encounter.

• Somatic recombination: the primary source of BCR and TCR diversity; recombines gene segments to create unique receptors.

• B cells also undergo somatic hypermutation to further diversify antibodies.

• The collective array of lymphocytes with different receptors constitutes the individual’s lymphocyte repertoire.

Tolerance and Self-Nonself Discrimination

• Repertoire generation risks self-reactivity due to random receptor creation; tolerance mechanisms prevent autoimmunity.

• Central tolerance: eliminates self-reactive clones during lymphocyte development (thymic education for T cells; bone marrow development for B cells).

• Peripheral tolerance: additional silencing or inactivation of self-reactive cells that escape central tolerance.

Interplay between Innate and Adaptive Responses

• Immune response progresses through three broad, overlapping phases.

• Phase 1: innate barriers provide immediate, non-specific protection (non-inducible).

• Phase 2: inducible innate responses activate within 4–96 hours if barriers fail, including complement, innate leukocytes, inflammation, phagocytosis, and platelets of innate action.

• Phase 3: adaptive immunity is engaged when innate responses are insufficient; Th, Tc, and B cells proliferate and differentiate into memory and effector cells to clear the pathogen.

• Innate and adaptive responses are tightly interwoven; innate components activate and shape adaptive responses, while adaptive responses enhance innate immunity via cytokines and cell interactions.

• Cytokine signaling and direct cell-to-cell contact sustain this cooperation.

• Research focus: the race between infection and immunity; threshold effects and antigen availability influence whether vaccines can provoke robust memory responses (threshold hypothesis).

Three Phases of Host Immune Defense (Fig. 1-7 and 1-8)

• Phase 1: pre-existing barriers for immediate protection (skin, mucosae, gut enzymes) – non-inducible.

• Phase 2: innate inducible defense 4–96 hours after entry; complement and innate leukocytes eliminate the invader; inflammation and phagocytosis central.

• Phase 3: adaptive immunity activated if innate is insufficient; Th, Tc, B cells clonally selected; memory and effector populations generated; slower onset but highly specific and potent.

• Innate and adaptive immunity coordinate to provide a full spectrum of responses with appropriate strength and specificity.

Clinical Immunology: Health, Disease, and Pathology

• Normal immune function confers immunity to infections and may be enhanced by vaccination.

• Immunodeficiencies: primary (congenital) or acquired (e.g., due to nutritional imbalance or HIV/AIDS); lead to susceptibility to infections and tumors.

• Immunopathology: inappropriate immune actions cause disease states.

• Transplant rejection: immune response to foreign tissue; needs immunosuppression or tolerance induction.

• Autoimmune disease: loss of tolerance leading to self-tissue attack.

• Hypersensitivity: excessive or inappropriate immune response causing tissue damage.

• Chronic inflammation: prolonged inflammatory response can contribute to tumor, heart disease, or autoimmune conditions.

• The chapter previews chapters on deeper topics: basic immunology (Ch. 2), innate and adaptive sections (Chs. 3–12), clinical immunology (Chs. 13–20).

• The book aims to explain cellular and molecular mechanisms of immunity and how dysregulation leads to illness; also discusses manipulation of immune mechanisms for health.

Notes on Figures and Key Terms

• PAMPs: pathogen-associated molecular patterns; recognized by PRMs on innate leukocytes.

• DAMPs: damage-associated molecular patterns; released by damaged or dying host cells; trigger innate responses.

• PRMs/PRRs: pattern recognition molecules/receptors; enable broad recognition in innate immunity and initiation of inflammatory responses.

• MHC I: presents intracellular pathogen-derived peptides to Tc cells; expressed on nearly all nucleated cells; enables CTL-mediated lysis.

• MHC II: presents extracellular pathogen-derived peptides to Th cells; expressed by APCs (DCs, macrophages, B cells).

• APCs (antigen-presenting cells): DCs are key; phagocytose pathogens and present peptides on MHC for T cell activation.

• BCR: B cell receptor; recognizes intact antigen; triggers B cell proliferation and antibody production.

• TCR: T cell receptor; recognizes pMHC complexes; cannot recognize native antigens directly.

• CTLs: cytotoxic T lymphocytes; derived from Tc cells; lyse infected or malignant cells.

• Plasma cells: antibody-secreting descendants of B cells; mediate humoral immunity.

• Immunological memory: long-lived memory B and T cells ready to respond rapidly on re-exposure.

• Clonal selection: antigen triggers only specific lymphocytes bearing receptors for that antigen to proliferate.

• Somatic recombination: genetic mechanism generating diverse BCRs and TCRs.

• Central and peripheral tolerance: mechanisms to prevent self-reactive lymphocytes from causing damage.

• Threshold hypothesis: the concept that pathogen replication rate and antigenic/PRM load influence activation and vaccination efficacy for fast vs slow pathogens.

Summary Takeaways

• The immune system comprises innate and adaptive components that are interdependent and co-evolve to maintain homeostasis.

• Innate immunity provides immediate, non-specific defense and shapes the adaptive response; adaptive immunity provides highly specific, memory-based protection.

• Antigen recognition in the adaptive system is tightly specific, whereas innate recognition is broad but non-specific; memory differentiates adaptive responses from innate.

• A complex interaction between barriers, innate responses, and adaptive responses determines the outcome of infections and the risk of immune-mediated disease.

• Immunodeficiencies, hypersensitivities, autoimmunity, transplant rejection, and chronic inflammation illustrate both the necessity and potential excesses of immune function.

• Vaccination leverages immunological memory to provide protection, with efficacy influenced by pathogen replication rates and antigen availability.

• The immune system’s balance is dynamic, with ongoing research refining our understanding of thresholds, memory, and tolerance to improve health outcomes.